Funding Opportunities

Grants for melanoma and skin cancer clinical research

Melanoma and Skin Cancer Trials conducts investigator-initiated clinical trials and related research to improve how doctors prevent, diagnose and treat melanoma and skin cancer.

We have built an impressive reputation for delivering multicentre trials that improve melanoma and skin cancer outcomes across the world. Since 1999, we have delivered 29 clinical trials involving over 7,500 participants.

Melanoma and Skin Cancer Trials facilitates the development of competitive investigator-initiated proposals through our concept development pathway. For more information on how we can help you develop a research proposal and secure funding, contact us.

Discovery Projects Expressions of Interest for funding commencing in 2026 - GO7291

Open Date

31 October 2024

Closing Date

13 December 2024

Grant amount

$30,000 – $2,500,00 AUD

About

The Discovery Projects scheme provides grant funding to support research projects that may be undertaken by individual researchers or research teams.

The Discovery Projects scheme objectives are to:

  • Support excellent pure basic, strategic basic and applied research, and research training, across all disciplines excluding clinical and other medical research, that addresses a significant problem or gap in knowledge and represents value for money;
  • Expand research capacity in Australia by supporting excellent researchers and teams;
  • Foster national and international research collaboration;
  • Create new knowledge with economic, commercial, environmental, social and/or cultural benefits for Australia; and
  • Enhance the scale and focus of research in Australian Government priority areas.

MRFF - 2024 International Clinical Trial Collaborations Grant Opportunity - GO6825

Open Date

6 March 2024

Closing Date

5 February 2025

Grant amount

$3,000,000 AUD (Total amount available $12,600,000 AUD)

About

The Clinical Trials Activity Initiative (the Initiative) aims to:

  • Improve the evidence base supporting clinical care
  • Help patients access trials relevant to their health circumstances
  • Enable researchers to bring international trials to Australian patients

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

  • Promote Australian involvement in international collaborative investigator-initiated clinical trials research through the establishment and co-ordination of clinical trial site/s in Australia.
  • Provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an Australian setting.

MRFF 2024 National Critical Research Infrastructure Grant Opportunity - MRFF 2024 NCRII

Open Date

4 October 2024

Closing Date

31 March 2025

Grant amount

$7,000,000 AUD

About

The 2024 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.

Stream 1 – Innovation enablers: Addresses an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel research platforms, and secure health data environments to create valuable research resources.

Stream 2 – Digitisation of health care: Developing and translating into practice digital therapeutics, artificial intelligence enabled health interventions and technologies (e.g. wearables integrated into clinical practice), applications or other software for use in clinical practice.

Stream 3 – Co-investment partnerships: Utilising co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment).

Stream 4 – mRNA technology enablers: Leveraging and enhancing emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.

MRFF 2024 Clinical Trials Activity Grant Opportunity - GO7146

Open Date

4 September 2024

Closing Date

2 April 2025

Grant amount

$5,000,000 AUD (Total amount: $63,000,000 AUD)

About

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

  • Stream 1 (Targeted Call for Research): conduct a pilot study to assess the feasibility of a new clinical trial for one or more treatments and/or management strategies for a rare cancer, rare disease and/or unmet need.
  • Stream 2 (Targeted Call for Research): conduct a clinical trial of one or more treatments and/or management-based interventions for rare cancers, rare diseases and/or unmet need.
  • Stream 3 (Targeted Call for Research): conduct a clinical trial that assesses the comparative effectiveness of two or more health interventions to treat a specific clinical condition, to inform the decisions of policy makers, clinicians, and consumers regarding healthcare and to minimise the use of unnecessary, ineffective, and harmful health interventions.
  • Stream 4 (Targeted Call for Research): conduct an implementation science trial to determine the best ways to implement a proven preventive health intervention, screening or diagnostic test, therapeutic agent, technology or model of care that is not in routine use in Australia.

MRFF – EPCDRI – 2024 Integrated Multidisciplinary Models of Primary Care Grant Opportunity - GO7154

Open Date

11 September 2024

Closing Date

2 April 2025

Grant amount

$2,000,000 AUD (Total amount: $8,000,000 AUD)

About

The Medical Research Future Fund (MRFF) – Emerging Priorities and Consumer Driven Research Initiative (EPCDRI) – 2024 Integrated Multidisciplinary Models of Primary Care Grant Opportunity will support medical research and medical innovation projects that evaluate the effectiveness and feasibility of new or existing models of integrated, multidisciplinary team-based primary care for people who would most benefit from this type of care, including but not limited to First Nations Australians, people from culturally and linguistically diverse backgrounds, people with disability including intellectual, children, older populations (either in residential aged care homes or those ageing at home), or those with social disadvantage or multiple chronic conditions.

Three streams of funding are available based on the health service provider or geographic location of the organisation undertaking the majority of the research:

  • Stream 1 (Targeted Call for Research): The organisation undertaking the majority of the research must be located in any area according to the Modified Monash Model (MM1-7)
  • Stream 2 (Targeted Call for Research): The organisation undertaking the majority of the research is located in, and the Chief Investigator A and 50% or more of all Chief Investigators, and all research participants, are primarily resident in, a rural or remote area according to the Modified Monash Model (MM3-7)
  • Stream 3 (Targeted Call for Research): The organisation undertaking the majority of the research must be an Aboriginal Community Controlled Health Service.

Applicants to this grant opportunity must propose research that addresses one of the three Streams of research.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.

Further information on the Medical Research Future Fund is available from the Department of Health and Aged Care’s website.

Cancer Patient Care Program - GO6736

Open Date

2 April 2024

Closing Date

1 August 2025

Grant amount

$1,000,000 AUD (Total amount available $16,500,000 AUD)

Application website

About

This grant opportunity seeks to ensure that all Australian’s living with cancer have access to high-quality and culturally safe support throughout their cancer experience. Acknowledging the existing national cancer screening programs and funding provided for more commonly diagnosed cancers, this grant opportunity will prioritise activities that focus on increasing equity across tumour types and/or priority populations.

The Cancer Patient Support Program (the Program) will support, one-off, time-limited activities that provide national leadership on emerging priorities across the cancer control continuum.

MRFF 2022 Frontier Health and Medical Research Grant Opportunity - GO5855

Open Date

13 February 2023

Closing Date

31 March 2026

Grant amount

$25,000,000 AUD (Total amount: $40,000,000 AUD)

About

This grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.